Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin
- PMID: 17961734
- DOI: 10.1016/j.regpep.2007.09.024
Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin
Abstract
CCK receptors represent potential targets in a number of diseases. Knowledge of CCK receptor binding sites is a prerequisite for the understanding of the molecular basis for their ligand recognition, partial agonism, ligand-induced trafficking of signalling. In the current paper, we report studies from our laboratory and others which have provided new data on the molecular basis of the pharmacology and functioning of CCK1 and CCK2 receptors. It has been shown that: 1) homologous regions of the two receptors are involved in the binding site of CCK, however, positioning of CCK slightly differs in agreement with distinct pharmacophores of CCK toward the two receptors and receptor sequence variations; 2) Binding sites of most of non-peptide agonists/ antagonist are buried in the pocket formed by transmembrane helices and overlap that of CCK; Aromatic amino acids within and near the binding site, especially in helix VI, are involved in receptor activation; 4) Like for other members of family A of G-protein coupled receptors, residues of the binding sites as well as of conserved motifs such as E/DRY, NPXXY are crucial for receptor activation.
Similar articles
-
Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.Pharmacol Toxicol. 2002 Dec;91(6):313-20. doi: 10.1034/j.1600-0773.2002.910608.x. Pharmacol Toxicol. 2002. PMID: 12688374 Review.
-
Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.Peptides. 2007 Nov;28(11):2211-22. doi: 10.1016/j.peptides.2007.09.008. Epub 2007 Sep 22. Peptides. 2007. PMID: 17950490
-
Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling.Biopolymers. 1997 Jun;41(7):799-817. doi: 10.1002/(SICI)1097-0282(199706)41:7<799::AID-BIP8>3.0.CO;2-K. Biopolymers. 1997. PMID: 9128441
-
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.Protein Sci. 1999 Nov;8(11):2347-54. doi: 10.1110/ps.8.11.2347. Protein Sci. 1999. PMID: 10595537 Free PMC article.
-
Cholecystokinin and gastrin receptors.Physiol Rev. 2006 Jul;86(3):805-47. doi: 10.1152/physrev.00014.2005. Physiol Rev. 2006. PMID: 16816139 Review.
Cited by
-
The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.Eur J Clin Invest. 2016 Feb;46(2):158-69. doi: 10.1111/eci.12580. Epub 2016 Jan 12. Eur J Clin Invest. 2016. PMID: 26683129 Free PMC article.
-
Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors.Amino Acids. 2011 Nov;41(5):1049-58. doi: 10.1007/s00726-010-0501-y. Epub 2010 Mar 3. Amino Acids. 2011. PMID: 20198494 Free PMC article. Review.
-
Structures of the human cholecystokinin receptors bound to agonists and antagonists.Nat Chem Biol. 2021 Dec;17(12):1230-1237. doi: 10.1038/s41589-021-00866-8. Epub 2021 Sep 23. Nat Chem Biol. 2021. PMID: 34556863
-
Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations.Front Pharmacol. 2023 Jan 23;13:1054575. doi: 10.3389/fphar.2022.1054575. eCollection 2022. Front Pharmacol. 2023. PMID: 36756145 Free PMC article.
-
Gastrin induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C-dependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human.Endocrinology. 2013 Feb;154(2):865-75. doi: 10.1210/en.2012-1813. Epub 2012 Dec 28. Endocrinology. 2013. PMID: 23275470 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources